Stratos Wealth Partners’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,403
Closed -$800K – 1728
2026
Q2
$800K Buy
19,403
+3,112
+19% +$118K 0.01% 943
2026
Q1
$598K Buy
+16,291
New +$593K 0.01% 992

Other funds holding CANC

Stratos Wealth Partners's CANC Position: Q3 2026 in Review

Stratos Wealth Partners sold out of Tema Oncology ETF (CANC) in Q3 2026, closing a stake of 19,403 shares — an estimated $800K sold.

Stratos Wealth Partners first reported a position in CANC in Q1 2026 and held it in 2 quarters. The position peaked at $800K in Q2 2026. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

  • Stratos Wealth Partners reported no remaining Tema Oncology ETF position as of Q3 2026 after selling out during the quarter.
  • Stratos Wealth Partners sold 19,403 Tema Oncology ETF shares in Q3 2026, an estimated $800K.
  • Stratos Wealth Partners first reported a position in Tema Oncology ETF in Q1 2026 and held it in 2 quarters.
  • Stratos Wealth Partners's Tema Oncology ETF position peaked at $800K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Stratos Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.